These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 21796370)

  • 1. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
    Deiana S; Watanabe A; Yamasaki Y; Amada N; Arthur M; Fleming S; Woodcock H; Dorward P; Pigliacampo B; Close S; Platt B; Riedel G
    Psychopharmacology (Berl); 2012 Feb; 219(3):859-73. PubMed ID: 21796370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
    Piscitelli F; Pagano E; Lauritano A; Izzo AA; Di Marzo V
    Anal Chem; 2017 Apr; 89(8):4749-4755. PubMed ID: 28343385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
    Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis sativa: Much more beyond Δ
    Alves P; Amaral C; Teixeira N; Correia-da-Silva G
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances.
    Farrelly AM; Vlachou S; Grintzalis K
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Route of Administration and Vehicle on the Pharmacokinetics of THC and CBD in Adult, Neonate, and Breastfed Sprague-Dawley Rats.
    Soni I; Chinn GA; Halifax JC; Hellman J; Lynch KL; Sall JW
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):e1443-e1451. PubMed ID: 37852006
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
    Rock EM; Sticht MA; Duncan M; Stott C; Parker LA
    Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol.
    Pagano E; Montanaro V; Di Girolamo A; Pistone A; Altieri V; Zjawiony JK; Izzo AA; Capasso R
    Nat Prod Commun; 2015 Jun; 10(6):1009-12. PubMed ID: 26197538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM; Duncan M; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
    Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
    Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
    O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
    Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terpenes and Cannabinoids Yields and Profile from Direct-Seeded and Transplanted CBD-
    Zheljazkov VD; Noller JS; Maggi F; Dale R
    J Agric Food Chem; 2022 Aug; 70(34):10417-10428. PubMed ID: 35436102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
    Fernández-Trapero M; Pérez-Díaz C; Espejo-Porras F; de Lago E; Fernández-Ruiz J
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β-evoked neurotoxicity and changes in cell morphology in PC12 cells.
    Marsh DT; Sugiyama A; Imai Y; Kato R; Smid SD
    Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):293-309. PubMed ID: 37697481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats.
    Salau O; Bagde A; Kalvala A; Singh M
    Int J Pharm; 2022 Aug; 624():122016. PubMed ID: 35863593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.
    Iannotti FA; Pagano E; Moriello AS; Alvino FG; Sorrentino NC; D'Orsi L; Gazzerro E; Capasso R; De Leonibus E; De Petrocellis L; Di Marzo V
    Br J Pharmacol; 2019 May; 176(10):1568-1584. PubMed ID: 30074247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.